↓ Skip to main content

Chronic myeloid leukemia: the paradigm of targeting oncogenic tyrosine kinase signaling and counteracting resistance for successful cancer therapy

Overview of attention for article published in Molecular Cancer, February 2018
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (51st percentile)
  • Above-average Attention Score compared to outputs of the same age and source (57th percentile)

Mentioned by

patent
1 patent

Citations

dimensions_citation
152 Dimensions

Readers on

mendeley
209 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Chronic myeloid leukemia: the paradigm of targeting oncogenic tyrosine kinase signaling and counteracting resistance for successful cancer therapy
Published in
Molecular Cancer, February 2018
DOI 10.1186/s12943-018-0780-6
Pubmed ID
Authors

Simona Soverini, Manuela Mancini, Luana Bavaro, Michele Cavo, Giovanni Martinelli

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 209 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 209 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 30 14%
Student > Master 25 12%
Student > Ph. D. Student 18 9%
Researcher 17 8%
Student > Postgraduate 11 5%
Other 32 15%
Unknown 76 36%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 49 23%
Medicine and Dentistry 26 12%
Pharmacology, Toxicology and Pharmaceutical Science 14 7%
Agricultural and Biological Sciences 11 5%
Immunology and Microbiology 10 5%
Other 21 10%
Unknown 78 37%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 January 2024.
All research outputs
#8,537,346
of 25,377,790 outputs
Outputs from Molecular Cancer
#692
of 1,918 outputs
Outputs of similar age
#139,112
of 344,184 outputs
Outputs of similar age from Molecular Cancer
#21
of 59 outputs
Altmetric has tracked 25,377,790 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,918 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.8. This one has gotten more attention than average, scoring higher than 51% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 344,184 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 51% of its contemporaries.
We're also able to compare this research output to 59 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 57% of its contemporaries.